ImpactOS
See an example

GSK

Companies and groups · United Kingdom

In these lists: Medicines

Declared lobbying cost
€1,000,000 – €1,249,999 Financial year 01/2025-12/2025
Commission meetings
9
Full-time staff on EU lobbying
3.3
European Parliament access passes
4
Registered since
6 Jan 2009
Public records onlyWhat this means

Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself

Registering is a legal transparency duty, not a sign of wrongdoing. Budgets and meetings show access, not influence on any particular decision. Register figures as declared on 30 Jun 2026

Fields of interest

Business and industry, Competition, Digital economy and society, Economy, finance and the euro, Employment and social affairs, Environment, External relations, Humanitarian aid and civil protection, Institutional affairs, International co-operation and development, Public health, Research and innovation, Single market, Taxation, Trade

Medicines and food topics they name

EU medicines law, Critical medicines, Vaccines, Antibiotics and antimicrobials

EU laws and policies they declare following1
  • Revision EU Pharmaceutical legislation, European Health Data Space Regulation, EU AI Act, Urban Waste Water Treatment Directive, F-Gas Regulation, Vaccination Policy, R&D policy / IHI, Antimicrobial…

Meetings with the Commission

Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them

  1. With the Commissioner

    Olivér Várhelyi

    Life Sciences Roundtable

    Published record
  2. With the Commissioner

    Olivér Várhelyi

    Challenges and priorities for health and life sciences

    Published record
  3. With the Cabinet

    Olivér Várhelyi

    Challenges and priorities for health and life sciences

    Published record
  4. With the Commissioner

    Olivér Várhelyi

    Digital and AI as an enabler in healthcare

    Published record
  5. With the Cabinet

    Olivér Várhelyi

    Digital and AI as an enabler in healthcare

    Published record
  6. With the Commissioner

    Olivér Várhelyi

    Consumer protection dimension of specific dossiers

    Published record
  7. With the Cabinet

    Olivér Várhelyi

    Consumer protection dimension of specific dossiers

    Published record
  8. With the Commissioner

    Hadja Lahbib

    Working visit to GSK vaccine production site.

    Published record
  9. With the Cabinet

    Hadja Lahbib

    Working visit to GSK vaccine production site.

    Published record

Official entries

Checked against sources on 11 Nov 2026